A phase II study of irinotecan + temozolomide in children with recurrent neuroblastoma.
Phase of Trial: Phase II
Latest Information Update: 06 Oct 2014
At a glance
- Drugs Irinotecan (Primary) ; Temozolomide (Primary)
- Indications Neuroblastoma
- Focus Therapeutic Use
- 31 Aug 2018 Biomarkers information updated
- 16 Sep 2014 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov record.
- 02 Dec 2013 Planned End Date changed from 1 May 2007 to 1 Mar 2009 as reported by ClinicalTrials.gov record.